An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation

• Shengze Yu,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden

  ⨯
• Amira Alkharusi,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

  ⨯
• Gunnar Norstedt,

  Roles Conceptualization, Investigation, Methodology, Supervision, Writing – original draft

  Affiliations College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman, Center for Molecular Medicine, Karolinska Institute, Solna, Stockholm, Sweden

  ⨯
• Torbjörn Gräslund

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft

  * E-mail: torbjorn@kth.se

  Affiliation Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden

  http://orcid.org/0000-0002-5391-600X

  ⨯